 |
市場調查報告書
商品編碼
2050977
溶瘤病毒療法市場：依產品類型、應用、研發階段、通路和地區分類Oncolytic Virus Therapy Market, By Product Type, By Application , By Development Stage, By Distribution Channel, By Region |
||||||
2026年溶瘤病毒療法市場規模估計為2,240萬美元，預計2033年將達到1.109億美元。預計2026年至2033年，該市場將以25.7%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 2240萬美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 25.70% | 2033年市場規模預測： | 1.109億美元 |
溶瘤病毒療法是一種極具前景的癌症治療方法，它利用經過改造的病毒選擇性地靶向並摧毀癌細胞，同時不損傷健康細胞。利用病毒治療癌症的概念可以追溯到20世紀初，研究人員觀察到病毒感染疾病患者的腫瘤出現消退。 1990年代，隨著基因工程技術的進步，溶瘤病毒療法發展迅速，科學家得以改造病毒以增強其腫瘤特異性和治療效果。溶瘤病毒可以感染癌細胞並在其中複製，誘導細胞裂解或刺激身體產生對腫瘤的免疫反應。目前的研究重點在於最佳化病毒平台、開發聯合治療以及拓展溶瘤病毒療法在多種癌症中的應用。學術界、製藥公司和研究機構之間的合作正在推動新型溶瘤病毒療法的研發，人們對癌症治療方法的進步寄予厚望。
市場動態
全球溶瘤病毒療法市場正經歷強勁成長，這主要得益於病毒工程技術的進步、對癌症生物學更深入的理解、成功的臨床試驗以及對創新癌症治療方法日益成長的需求。此外，對新癌症適應症的探索、旨在改善治療效果的聯合治療、個人化醫療方法以及增強型下一代病毒的開發，預計將在不久的將來創造廣泛的市場機會。市場趨勢包括病毒療法平台、標靶遞送系統和免疫調節策略的進步，以及解決該領域在生產和商業化方面面臨的挑戰。此外，市場參與企業正致力於合作藥物開發，預計將推動全球溶瘤病毒療法市場的成長。例如，2023年6月29日，兩家處於臨床後期階段的生物製藥公司Genelux Corporation和TVAX Biomedical, Inc.宣布，美國專利商標局已授予其一項專利，該專利涉及一種將疫苗增強的過繼性T細胞療法與溶瘤病毒輔助性治療相結合的方法。該專利已獨家授權給V2ACT Therapeutics, LLC，該公司是由Genelux和TVAX共同成立的合資企業，旨在開發和測試V2ACT免疫療法。若專利期限未延長，專利將於2036年到期，為V2ACT免疫療法提供實質的智慧財產權保護。
然而，缺乏臨床證據、管理和分銷方面的挑戰、高成本以及治療副作用預計將阻礙市場成長。克服這些挑戰對於最大限度地發揮溶瘤病毒療法的療效和實現更廣泛的應用至關重要。
本次調查的主要特點
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數對全球溶瘤病毒療法市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份全球溶瘤病毒療法市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
- 透過分析全球溶瘤病毒療法市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 病毒學進展
- 加深我們對癌症生物學的理解
- 臨床試驗取得正面結果
- 對創新癌症治療方法的需求
- 抑制因子
- 治療高成本
- 治療的副作用
- 機會
- 癌症新適應症的開發
- 透過結合多種治療方法來改善治療效果
- 個人化醫療方法
- 促進因素
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
第4章 溶瘤病毒療法市場：依產品類型分類，2021-2033年
- 單純皰疹病毒
- 腺病毒
- 牛痘病毒
- 呼腸孤病毒
- 麻疹病毒
- 其他病毒（新城疫病毒、水痘口炎病毒）
第5章 溶瘤病毒療法市場：依應用領域分類，2021-2033年
- 黑色素瘤
- 乳癌
- 頭頸癌
- 膀胱癌
- 攝護腺癌
- 肺癌
- 其他（結腸癌及其他）
第6章 溶瘤病毒療法市場：依研發階段分類，2021-2033年
- 商業的
- 管道階段
第7章 溶瘤病毒療法市場：依通路分類，2021-2033年
- 醫院藥房
- 零售藥房
- 網路藥房
第8章 溶瘤病毒療法市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第9章 競爭情勢
- Amgen Inc.
- Merck & Co., Inc.
- Oncolytics Biotech Inc.
- Circio Holding ASA
- Akamis Bio
- Vyriad, Inc.
- SillaJen Biotherapeutics
- Cold Genesys Inc.
- Sorrento Therapeutics, Inc.
- Takara Bio Inc.
- Replimune Group Inc.
- Genelux Corporation
- Synthetic Biologics, Inc
- Lokon Pharma AB
- Elicera Therapeutics
第10章
- 調查方法
- 關於本公司
Oncolytic Virus Therapy Market is estimated to be valued at USD 22.4 Mn in 2026 and is expected to reach USD 110.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 25.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 22.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 25.70% | 2033 Value Projection: | USD 110.9 Mn |
Oncolytic virus therapy is a promising approach to cancer treatment that utilizes modified viruses to selectively target and destroy cancer cells while sparing healthy cells. The concept for viruses for cancer treatment dates back to the early 20th century, when researchers observed tumor regression in patients with viral infections. The field gained momentum in the 1990s with advancements in genetic engineering, enabling scientists to modify viruses to enhance the tumor-specificity and therapeutic efficacy. Oncolytic viruses can infect cancer cells, replicate within them, and induce cell lysis or stimulate immune responses against the tumor. Ongoing research focuses on optimizing viral platforms, developing combination therapies, and expanding the application of oncolytic virus therapy to various cancer types. Collaborations between academia, pharmaceutical companies, and research institutions drive the development of novel oncolytic virus therapies and hold promise for advancing cancer treatment approaches.
Market Dynamics
The global oncolytic virus therapy market is witnessing strong growth on account of growing advancements in viral engineering, increasing understanding of cancer biology, successful clinical trial results, and the need for innovative cancer treatments. Moreover, exploring new cancer indications, combining therapies for improved outcomes, personalized medicine approaches, and the development of next-generation viruses with enhanced characteristics are expected to bring bright market opportunities in the near future. The market trends include advancements in virotherapy platforms, targeted delivery systems, immune modulation strategies, and addressing manufacturing and commercialization challenges in the field. Moreover, market players are focused on developing novel drugs by collaborating, which is expected to drive the growth of global oncolytic virus therapy market. For instance, on June 29, 2023, Genelux Corporation, a late clinical-stage biopharmaceutical company, and TVAX Biomedical, Inc., a late clinical-stage biopharmaceutical company, announced that the U.S. Patent and Trademark Office granted a patent claiming methods of combining vaccine-enhanced adoptive T cell therapy with oncolytic virus adjunct therapy. The patent has been exclusively licensed to V2ACT Therapeutics, LLC, a joint venture between Genelux and TVAX that was established for the purpose of developing and testing V2ACT immunotherapy. The patent expiry, prior to any patent term extension, will be in 2036 and will add substantial intellectual property protection for V2ACT immunotherapy.
However, limited clinical evidence, delivery and distribution challenges, high costs associated with treatment, and side effects of treatment are expected to hamper market growth. Overcoming these challenges is essential to maximizing the efficiency and broader adoption of oncolytic virus therapies.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global oncolytic virus therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study Amgen Inc., Merck & Co., Inc., Oncolytics Biotech Inc., Circio Holding ASA, Akamis Bio, Vyriad, Inc., SillaJen Biotherapeutics, Cold Genesys Inc., Sorrento Therapeutics, Inc., Takara Bio Inc., Replimune Group Inc., Genelux Corporation, Synthetic Biologics, Inc., Lokon Pharma AB, and Elicera Therapeutics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global oncolytic virus therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oncolytic virus therapy market.
Market Segmentation
- By Product Type (Revenue, USD Mn, 2021 - 2033)
- Herpes simplex virus
- Adenovirus
- Vaccinia virus
- Reovirus
- Measles virus
- Others (Newcastle disease virus, Vesicular stomatitis virus)
- By Application (Revenue, USD Mn, 2021 - 2033)
- Melanoma
- Breast cancer
- Head and neck cancer
- Bladder Cancer
- Prostate Cancer
- Lung Cancer
- Others (Colorectal Cancer, and among Others)
- By Development Stage (Revenue, USD Mn, 2021 - 2033)
- Commercial
- Pipeline Phase
- Pre-clinical
- Phase I
- Phase II
- Phase III
- By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in Oncolytic Virus Therapy Market
- Amgen Inc.
- Merck & Co., Inc.
- Oncolytics Biotech Inc.
- Circio Holding ASA
- Akamis Bio
- Vyriad, Inc.
- SillaJen Biotherapeutics
- Cold Genesys Inc.
- Sorrento Therapeutics, Inc.
- Takara Bio Inc.
- Replimune Group Inc.
- Genelux Corporation
- Synthetic Biologics, Inc.
- Lokon Pharma AB
- Elicera Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Oncolytic Virus Therapy Market, By Product Type
- Global Oncolytic Virus Therapy Market, By Application
- Global Oncolytic Virus Therapy Market, By Development Stage
- Global Oncolytic Virus Therapy Market, By Distribution Channel
- Global Oncolytic Virus Therapy Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Advancements in Viral Engineering
- Increasing Understanding of Cancer Biology
- Successful Clinical Trial Results
- Need for Innovative Cancer Treatments
- Restraints
- High cost associated with treatment
- Side effects of treatment
- Opportunities
- Exploring new cancer indications
- Combining therapies for improved outcomes
- Personalized medicine approaches
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Oncolytic Virus Therapy Market , By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Herpes Simplex Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Adenovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Vaccinia virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Reovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Measles virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Others (Newcastle disease virus, Vesicular stomatitis virus)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
5. Oncolytic Virus Therapy Market , By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Breast cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,( USD Mn)
- Head and neck cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,( USD Mn)
- Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,( USD Mn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,( USD Mn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Others (Colorectal Cancer, and among Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
6. Oncolytic Virus Therapy Market, By Development Stage, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Commercial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Pipeline Phase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Pre-clinical
- Phase I
- Phase II
- Phase III
7. Oncolytic Virus Therapy Market , By Distribution Channel, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
8. Oncolytic Virus Therapy Market , By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- U.K
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Oncolytics Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Circio Holding ASA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Akamis Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vyriad, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SillaJen Biotherapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cold Genesys Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sorrento Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Replimune Group Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genelux Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Synthetic Biologics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lokon Pharma AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elicera Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
溶瘤病毒療法市場報告：按病毒類型、應用、最終用途和地區分類（2026-2034 年）
溶瘤病毒療法市場：2026-2032年全球市場預測（按病毒類型、癌症適應症、給藥途徑和最終用戶分類）溶瘤病毒生產和開發服務市場（按服務類型、規模、病毒類型、合約類型、最終用戶和應用分類），全球預測，2026-2032年
溶瘤病毒療法市場－全球產業規模、佔有率、趨勢、機會及預測（按病毒類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）
溶瘤病毒療法市場規模、佔有率及成長分析（按病毒類型、癌症類型、治療方法、給藥途徑、最終用戶和地區分類）－2026-2033年產業預測
溶瘤病毒療法：全球市場佔有率和排名、總收入和需求預測（2025-2031年）溶瘤病毒治療市場 - 全球產業規模、佔有率、趨勢、機會和預測，按病毒類型、應用、最終用戶、地區和競爭細分，2020-2030 年預測